Larazotide (AT-1001)
Larazotide acetate is an 8-amino-acid peptide that acts as a tight junction regulator in the gut epithelium, showing promise for treating leaky gut syndrome and celiac disease.
Protocol
0.5–2 mg oral, 3x daily
Half-Life
2–4 hours
Molecular Structure & Chemistry
20 residues • 328 atoms • Skeletal Formula
C106H162N30O28S2
2,008.45 g/mol
2367.162 Da
9.77
+1.93
-0.33
Amino Acid Sequence
Biological Mechanisms
Reduces intestinal permeability
Observed in clinical research as a primary mechanism of action for Larazotide (AT-1001).
Celiac disease management
Observed in clinical research as a primary mechanism of action for Larazotide (AT-1001).
Tight junction stabilization
Observed in clinical research as a primary mechanism of action for Larazotide (AT-1001).
Reduces GI inflammation
Observed in clinical research as a primary mechanism of action for Larazotide (AT-1001).
Safety & Risk Analysis
Critical Safety Warning
Black market peptides can be contaminated, mislabeled, or dangerous. Only obtain peptides via a registered doctor and legitimate pharmacy. Never attempt self-administration without professional medical supervision.
Community Journey Log
Log Your Journey
Share your research observations with the community.
Sign in to contribute
Create a free account to log your research journey and share observations with the community.
Community Observations (0)
No journey logs yet. Be the first to share.
This compound is for research purposes only. Clinical applications must be directed by a licensed physician.
View Community Logs